[Experimental Studies on Adriamycin Alginate-Chitosan Microcapsules in the Treatment of Rabbit VX2 Carcinoma in the Extremity].

Xiao-dong Tang,Wei Guo,Yi Guo,Sha Li,Xinpu Hou
DOI: https://doi.org/10.3760/j:issn:0529-5815.2003.12.016
2003-01-01
Abstract:OBJECTIVETo study the effects of chemoembolization with adriamycin alginate-chitosan microcapsules in the treatment of VX2 carcinoma in the extremity of the rabbit.METHODSTwenty-four New Zealand white rabbits transplanted with VX2 carcinoma cells into the muscle tissue of the lower right thigh were divided into four groups namely groups A, B, C and D, and received regional infusion from femoral artery. Each group consisted of six rabbits: a group given natural saline (Group A), a group given adriamycin (Group B), a group given blank alginate-chitosan microcapsules (Group C) and a group given adriamycin alginate-chitosan microcapsules (Group D). Three days after treatment, all groups were examined by histology and immunohistochemical detection (TdT-mediated dUTP nick end labeling technique, TUNEL; proliferating cell nuclear antigen, PCNA).RESULTSThe blood vessels of the tumor were almost embolized by the microcapsules. Extensive necrosis, high level of positive cells in TUNEL (60.85% +/- 5.21%) and low level in PCNA detection with in the tumors were observed in Group D.CONCLUSIONAdriamycin alginate-chitosan microcapsules can potentially play roles in two respects, 1 to serve as embolizing agents, and 2 to serve as drug delivery vehicles for local release. Chemoembolization with microparticals is an effective treatment of malignant osseous and soft tissue sarcomas in an experimental model.
What problem does this paper attempt to address?